8-K Announcements
6Material company update
Apr 14, 2026·SEC
Material company update
Mar 11, 2026·SEC
Material company update
Nov 6, 2025·SEC
Codexis, Inc.(CDXS)Earnings, Financials & Key Ratios
CDXS•NASDAQ
$2.66
$242M mkt cap·Price updated May 6, 2026
AboutCodexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.Show more
- Revenue$70M+18.6%
- EBITDA-$30M+48.8%
- Net Income-$44M+32.6%
- EPS (Diluted)-0.50+43.8%
- Gross Margin79.49%+9.6%
- EBITDA Margin-42.68%+56.8%
- Operating Margin-54.46%+44.8%
- Net Margin-62.47%+43.2%
- ROE-74.88%+11.9%
- ROIC-31.85%+47.4%
- Debt/Equity1.45+61.9%
- Interest Coverage-7.96
CDXS Key Insights
Codexis, Inc. (CDXS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 94 (top 6%)
✗Weaknesses
- ✗Profits declining 12.9% over 5 years
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 18.7% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CDXS Price & Volume
Codexis, Inc. (CDXS) stock price & volume — 10-year historical chart
Loading chart...
CDXS Growth Metrics
Codexis, Inc. (CDXS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.35%
5 Years0.38%
3 Years-20.22%
TTM18.61%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM32.63%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM42.22%
Return on Capital
10 Years-32.89%
5 Years-31.14%
3 Years-42.59%
Last Year-30.93%
CDXS Recent Earnings
Codexis, Inc. (CDXS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
Mar 11, 2026EPS
$0.11
Est $0.01
+1000.0%
Revenue
$39M
Est $36M
+8.6%
Q4 2025
Nov 6, 2025EPS
$0.22
Est $0.15
-46.7%
Revenue
$9M
Est $36M
-76.0%
Q3 2025
Aug 13, 2025EPS
$0.16
Est $0.17
+5.9%
Revenue
$15M
Est $19M
-21.3%
Q2 2025
May 14, 2025EPS
$0.25
Est $0.20
-25.0%
Revenue
$8M
Est $10M
-21.9%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 11, 2026 | $0.11vs $0.01+1000.0% | $39Mvs $36M+8.6% |
| Q4 2025 | Nov 6, 2025 | $0.22vs $0.15-46.7% | $9Mvs $36M-76.0% |
| Q3 2025 | Aug 13, 2025 | $0.16vs $0.17+5.9% | $15Mvs $19M-21.3% |
| Q2 2025 | May 14, 2025 | $0.25vs $0.20-25.0% | $8Mvs $10M-21.9% |
Based on last 12 quarters of dataView full earnings history →
CDXS Peer Comparison
Codexis, Inc. (CDXS) competitors in Life Science Tools and Reagents — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 GEVO | 497.05M | 2.05 | -14.64 | 8.49% | 0.75% | 0.25% | 0.01 | |
 BEAM | 3.32B | 32.33 | -39.92 | 120.01% | -57.24% | -7.31% | 0.24 | |
 TRMK | 2.64B | 44.92 | 12.14 | 34.75% | 10.77% | 0.53 | ||
 NUVB | 1.75B | 5.04 | -8.40 | 6.99% | -102.06% | -44.1% | 0.03 | |
 RCKT | 418.11M | 3.86 | -1.92 | -80.49% | 0.09 | |||
 CRBU | 182.26M | 1.95 | -1.23 | -100% | -16.9% | -80.77% | 0.22 | |
 NTLA | 1.61B | 13.85 | -3.64 | -100% | -61.47% | 0.14 | ||
 MRK | 280.48B | 113.56 | 15.60 | 1.18% | 28.12% | 36.14% | 0.96 |
Compare CDXS vs Peers
Codexis, Inc. (CDXS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CDXS Income Statement
Codexis, Inc. (CDXS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 50.02M | 60.59M | 68.46M | 69.06M | 104.75M | 138.59M | 70.14M | 59.34M | 70.39M |
| Revenue Growth % | 2.43% | 21.13% | 12.98% | 0.87% | 51.69% | 32.3% | -49.39% | -15.39% | 18.61% |
| Cost of Goods Sold | 14.33M | 12.62M | 15.63M | 13.74M | 22.21M | 38.03M | 12.81M | 16.29M | 14.44M |
| COGS % of Revenue | 28.64% | 20.83% | 22.83% | 19.9% | 21.2% | 27.44% | 18.26% | 27.45% | 20.51% |
| Gross Profit | 35.7M▲ 0% | 47.97M▲ 34.4% | 52.83M▲ 10.1% | 55.31M▲ 4.7% | 82.55M▲ 49.2% | 100.56M▲ 21.8% | 57.33M▼ 43.0% | 43.06M▼ 24.9% | 55.95M▲ 29.9% |
| Gross Margin % | 71.36% | 79.17% | 77.17% | 80.1% | 78.8% | 72.56% | 81.74% | 72.55% | 79.49% |
| Gross Profit Growth % | -8.67% | 34.39% | 10.11% | 4.71% | 49.23% | 21.82% | -42.98% | -24.9% | 29.95% |
| Operating Expenses | 58.67M | 59.27M | 65.38M | 79.23M | 105.24M | 135.44M | 125.4M | 101.58M | 94.28M |
| OpEx % of Revenue | 117.28% | 97.81% | 95.5% | 114.74% | 100.47% | 97.73% | 178.78% | 171.16% | 133.95% |
| Selling, General & Admin | 29.01M | 29.29M | 31.5M | 35.05M | 49.32M | 52.17M | 53.25M | 55.15M | 47.07M |
| SG&A % of Revenue | 57.99% | 48.34% | 46.02% | 50.75% | 47.08% | 37.64% | 75.92% | 92.93% | 66.88% |
| Research & Development | 29.66M | 29.98M | 33.87M | 44.19M | 55.92M | 80.1M | 58.88M | 46.26M | 44.36M |
| R&D % of Revenue | 59.29% | 49.47% | 49.48% | 63.98% | 53.38% | 57.8% | 83.95% | 77.96% | 63.02% |
| Other Operating Expenses | -92K | -291K | 0 | 0 | 0 | 3.17M | 13.27M | 165K | 2.85M |
| Operating Income | -22.97M▲ 0% | -11.29M▲ 50.8% | -12.55M▼ 11.1% | -23.92M▼ 90.6% | -22.7M▲ 5.1% | -34.88M▼ 53.7% | -68.07M▼ 95.1% | -58.52M▲ 14.0% | -38.33M▲ 34.5% |
| Operating Margin % | -45.92% | -18.64% | -18.33% | -34.64% | -21.67% | -25.17% | -97.04% | -98.61% | -54.46% |
| Operating Income Growth % | -168.22% | 50.83% | -11.1% | -90.61% | 5.11% | -53.68% | -95.15% | 14.03% | 34.5% |
| EBITDA | -21.93M | -10.15M | -7.99M | -19.37M | -16.75M | -29.48M | -62.55M | -58.68M | -30.04M |
| EBITDA Margin % | -43.84% | -16.75% | -11.67% | -28.04% | -15.99% | -21.27% | -89.18% | -98.89% | -42.68% |
| EBITDA Growth % | -445.74% | 53.72% | 21.25% | -142.32% | 13.51% | -75.99% | -112.19% | 6.18% | 48.81% |
| D&A (Non-Cash Add-back) | 1.04M | 1.15M | 4.56M | 4.55M | 5.95M | 5.4M | 5.52M | -165K | 8.29M |
| EBIT | -22.97M | -11.29M | -12.55M | -23.92M | -22.7M | -31.71M | -54.8M | -58.35M | -38.33M |
| Net Interest Income | 147K | 671K | 1.29M | 405K | 459K | 1.44M | 4.17M | 3.67M | -2.19M |
| Interest Income | 147K | 671K | 1.29M | 405K | 459K | 1.44M | 4.17M | 3.67M | 2.63M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.81M |
| Other Income/Expense | 55K | 380K | 631K | 249K | 1.61M | 1.56M | -8.1M | -6.72M | -5.59M |
| Pretax Income | -22.91M▲ 0% | -10.91M▲ 52.4% | -11.92M▼ 9.2% | -23.67M▼ 98.6% | -21.09M▲ 10.9% | -33.32M▼ 58.0% | -76.17M▼ 128.6% | -65.24M▲ 14.3% | -43.93M▲ 32.7% |
| Pretax Margin % | -45.81% | -18.01% | -17.41% | -34.28% | -20.13% | -24.04% | -108.59% | -109.94% | -62.41% |
| Income Tax | 81K | -37K | 17K | 339K | 189K | 276K | 69K | 34K | 47K |
| Effective Tax Rate % | -0.35% | 0.34% | -0.14% | -1.43% | -0.9% | -0.83% | -0.09% | -0.05% | -0.11% |
| Net Income | -23M▲ 0% | -10.88M▲ 52.7% | -11.94M▼ 9.7% | -24.01M▼ 101.2% | -21.28M▲ 11.4% | -33.59M▼ 57.9% | -76.24M▼ 127.0% | -65.28M▲ 14.4% | -43.97M▲ 32.6% |
| Net Margin % | -45.97% | -17.95% | -17.43% | -34.77% | -20.31% | -24.24% | -108.69% | -109.99% | -62.47% |
| Net Income Growth % | -168.71% | 52.7% | -9.72% | -101.17% | 11.37% | -57.86% | -126.96% | 14.38% | 32.63% |
| Net Income (Continuing) | -23M | -10.88M | -11.94M | -24.01M | -21.28M | -33.59M | -76.24M | -65.28M | -43.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.50▲ 0% | -0.21▲ 58.0% | -0.21▲ 0.0% | -0.40▼ 90.5% | -0.33▲ 17.5% | -0.51▼ 54.5% | -1.12▼ 119.6% | -0.89▲ 20.5% | -0.50▲ 43.8% |
| EPS Growth % | -138.1% | 58% | 0% | -90.48% | 17.5% | -54.55% | -119.61% | 20.54% | 43.82% |
| EPS (Basic) | -0.50 | -0.21 | -0.21 | -0.40 | -0.33 | -0.51 | -1.12 | -0.89 | -0.50 |
| Diluted Shares Outstanding | 46.23M | 52.2M | 56.52M | 59.36M | 64.57M | 65.34M | 68.13M | 73.41M | 87.14M |
| Basic Shares Outstanding | 46.23M | 52.2M | 56.52M | 59.36M | 64.57M | 65.34M | 68.13M | 73.41M | 87.14M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
CDXS Balance Sheet
Codexis, Inc. (CDXS) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 45.04M | 67.2M | 114.2M | 184.42M | 161.89M | 162.89M | 93.47M | 98.77M | 96.82M |
| Cash & Short-Term Investments | 31.22M | 53.04M | 90.5M | 150.12M | 116.8M | 113.98M | 65.12M | 73.46M | 78.21M |
| Cash Only | 31.22M | 53.04M | 90.5M | 149.12M | 116.8M | 113.98M | 65.12M | 19.26M | 50.79M |
| Short-Term Investments | 0 | 0 | 0 | 1M | 0 | 0 | 0 | 54.19M | 27.42M |
| Accounts Receivable | 11.8M | 13.5M | 20.16M | 29.29M | 37.65M | 40.87M | 19.93M | 18.88M | 10.73M |
| Days Sales Outstanding | 86.1 | 81.33 | 107.46 | 154.8 | 131.19 | 107.65 | 103.7 | 116.15 | 55.64 |
| Inventory | 1.04M | 589K | 371K | 964K | 1.16M | 2.03M | 2.69M | 1.8M | 1.82M |
| Days Inventory Outstanding | 26.39 | 17.04 | 8.66 | 25.6 | 19.06 | 19.47 | 76.51 | 40.31 | 45.94 |
| Other Current Assets | 984K | 0 | 661K | 638K | 579K | 521K | 5.74M | 4.63M | 6.06M |
| Total Non-Current Assets | 8.59M | 11.09M | 34.87M | 37.22M | 84.5M | 87.5M | 43.09M | 50.24M | 50.98M |
| Property, Plant & Equipment | 2.81M | 4.76M | 30.39M | 31.18M | 65.46M | 61.88M | 28.62M | 42.9M | 43.52M |
| Fixed Asset Turnover | 17.77x | 12.73x | 2.25x | 2.22x | 1.60x | 2.24x | 2.45x | 1.38x | 1.62x |
| Goodwill | 3.24M | 3.24M | 3.24M | 3.24M | 3.24M | 3.24M | 2.46M | 2.46M | 2.46M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 671K | 588K | 0 | 1.45M | 14M | 20.51M | 9.7M | 2.8M | 2.5M |
| Other Non-Current Assets | 1.86M | 2.5M | 1.24M | 1.36M | 1.79M | 1.87M | 2.31M | 2.08M | 2.5M |
| Total Assets | 53.63M▲ 0% | 78.28M▲ 46.0% | 149.07M▲ 90.4% | 221.65M▲ 48.7% | 246.38M▲ 11.2% | 250.39M▲ 1.6% | 136.56M▼ 45.5% | 149.01M▲ 9.1% | 147.8M▼ 0.8% |
| Asset Turnover | 0.93x | 0.77x | 0.46x | 0.31x | 0.43x | 0.55x | 0.51x | 0.40x | 0.48x |
| Asset Growth % | 50.43% | 45.98% | 90.43% | 48.68% | 11.16% | 1.63% | -45.46% | 9.12% | -0.81% |
| Total Current Liabilities | 24.95M | 17.11M | 15.39M | 24.98M | 33.37M | 49.07M | 35.83M | 23.65M | 25.32M |
| Accounts Payable | 3.54M | 3.05M | 2.62M | 2.97M | 3M | 3.25M | 5.95M | 2.84M | 1.55M |
| Days Payables Outstanding | 90.31 | 88.21 | 61.2 | 78.89 | 49.22 | 31.15 | 169.46 | 63.6 | 39.29 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 12.29M | 3.94M | 57K | 1.82M | 2.59M | 13.73M | 10.12M | 350K | 7.01M |
| Other Current Liabilities | 4.36M | 5.8M | 5M | 10.27M | 11.12M | 11.45M | 11.25M | 11.41M | 13.81M |
| Current Ratio | 1.81x | 3.93x | 7.42x | 7.38x | 4.85x | 3.32x | 2.61x | 4.18x | 3.82x |
| Quick Ratio | 1.76x | 3.89x | 7.40x | 7.34x | 4.82x | 3.28x | 2.53x | 4.10x | 3.75x |
| Cash Conversion Cycle | 22.18 | 10.15 | 54.92 | 101.52 | 101.04 | 95.97 | 10.75 | 92.86 | 62.29 |
| Total Non-Current Liabilities | 4.13M | 4.86M | 28.17M | 26.56M | 48.62M | 56.53M | 14.12M | 58.44M | 71.95M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.91M | 40.1M |
| Capital Lease Obligations | 302K | 61K | 24.95M | 22.32M | 43.56M | 38.28M | 12.24M | 28.16M | 30.16M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.32M | 1.45M | 1.23M | 1.27M | 1.31M | 1.37M | 1.23M | 1.27M | 1.33M |
| Total Liabilities | 29.08M | 21.98M | 43.56M | 51.54M | 81.99M | 105.6M | 49.95M | 82.08M | 97.27M |
| Total Debt | 302K | 61K | 26.12M | 24.95M | 47.65M | 43.64M | 16.02M | 59.9M | 73.21M |
| Net Debt | -30.92M | -52.98M | -64.38M | -124.17M | -69.14M | -70.35M | -49.09M | 40.63M | 22.41M |
| Debt / Equity | 0.01x | 0.00x | 0.25x | 0.15x | 0.29x | 0.30x | 0.19x | 0.89x | 1.45x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | -7.96x |
| Total Equity | 24.55M▲ 0% | 56.31M▲ 129.4% | 105.52M▲ 87.4% | 170.1M▲ 61.2% | 164.39M▼ 3.4% | 144.8M▼ 11.9% | 86.61M▼ 40.2% | 66.93M▼ 22.7% | 50.53M▼ 24.5% |
| Equity Growth % | 28.53% | 129.38% | 87.4% | 61.21% | -3.36% | -11.92% | -40.18% | -22.73% | -24.5% |
| Book Value per Share | 0.53 | 1.08 | 1.87 | 2.87 | 2.55 | 2.22 | 1.27 | 0.91 | 0.58 |
| Total Shareholders' Equity | 24.55M | 56.31M | 105.52M | 170.1M | 164.39M | 144.8M | 86.61M | 66.93M | 50.53M |
| Common Stock | 5K | 5K | 6K | 6K | 6K | 6K | 7K | 8K | 9K |
| Retained Earnings | -315.06M | -330.47M | -342.41M | -366.42M | -387.7M | -421.29M | -497.53M | -562.81M | -606.78M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -472K | 0 | 0 | 0 | 0 | 0 | 0 | 52K | 8K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CDXS Cash Flow Statement
Codexis, Inc. (CDXS) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -8.76M | -14.09M | -12.56M | -16.46M | -14.27M | 11.28M | -52.64M | -49.41M | -19.38M |
| Operating CF Margin % | -17.52% | -23.26% | -18.35% | -23.84% | -13.62% | 8.14% | -75.04% | -83.26% | -27.53% |
| Operating CF Growth % | -224.44% | -60.84% | 10.88% | -31.08% | 13.34% | 179.09% | -566.48% | 6.13% | 60.79% |
| Net Income | -23M | -10.88M | -11.94M | -24.01M | -21.28M | -33.59M | -76.24M | -65.28M | -43.97M |
| Depreciation & Amortization | 1.04M | 1.15M | 4.56M | 4.55M | 5.95M | 10.25M | 9.92M | 4.95M | 5.25M |
| Stock-Based Compensation | 7.09M | 7.89M | 6.94M | 7.73M | 11.59M | 14.53M | 9.97M | 13.09M | 9.62M |
| Deferred Taxes | 9K | 0 | 0 | -900K | -2.88M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -207K | 91K | 525K | 55K | -19K | -1.48M | 21.93M | 9.85M | 3.31M |
| Working Capital Changes | 6.3M | -12.34M | -12.65M | -3.89M | -7.62M | 21.57M | -18.22M | -12.02M | 6.42M |
| Change in Receivables | -5.65M | 960K | 2.52M | -12.32M | -15.57M | -3.23M | 20.25M | 1.25M | 8.51M |
| Change in Inventory | -210K | 447K | 217K | -593K | -196K | -869K | -656K | 886K | -19K |
| Change in Payables | -801K | -524K | -428K | 101K | 268K | 207K | 2.29M | -2.57M | -1.29M |
| Cash from Investing | -908K | -2.77M | -3.67M | -5.75M | -21.42M | -13.58M | -4.86M | -56.98M | 23.5M |
| Capital Expenditures | -985K | -2.77M | -3.73M | -3.75M | -13.83M | -8.31M | -4.42M | -4.3M | -4.47M |
| CapEx % of Revenue | 1.97% | 4.57% | 5.45% | 5.43% | 13.2% | 5.99% | 6.3% | 7.25% | 6.35% |
| Acquisitions | 2K | 2K | 3K | 0 | 36K | 29K | 751K | 87K | 5K |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 77K | 2K | 3K | 0 | 36K | 29K | -440K | 0 | 0 |
| Cash from Financing | 21.65M | 38.57M | 53.96M | 80.81M | 3.77M | -575K | 8.17M | 60.52M | 27.93M |
| Debt Issued (Net) | -175K | -238K | -242K | -60K | 0 | 0 | 0 | 29.52M | 9.89M |
| Equity Issued (Net) | 23.78M | 37.5M | 50M | 86.25M | 4.97M | 913K | 8.65M | 31.32M | 18.03M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.96M | 1.31M | 4.2M | -5.38M | -1.21M | -1.49M | -485K | -318K | 0 |
| Net Change in Cash | 11.98M▲ 0% | 21.71M▲ 81.2% | 37.74M▲ 73.8% | 58.6M▲ 55.3% | -31.92M▼ 154.5% | -2.87M▲ 91.0% | -49.33M▼ 1619.4% | -45.87M▲ 7.0% | 32.05M▲ 169.9% |
| Free Cash Flow | -9.75M▲ 0% | -16.86M▼ 73.0% | -16.29M▲ 3.4% | -20.21M▼ 24.1% | -28.09M▼ 39.0% | 2.98M▲ 110.6% | -57.06M▼ 2016.6% | -53.72M▲ 5.9% | -23.85M▲ 55.6% |
| FCF Margin % | -19.49% | -27.83% | -23.8% | -29.27% | -26.82% | 2.15% | -81.34% | -90.51% | -33.88% |
| FCF Growth % | -171.61% | -72.98% | 3.39% | -24.08% | -39% | 110.6% | -2016.56% | 5.86% | 55.6% |
| FCF per Share | -0.21 | -0.32 | -0.29 | -0.34 | -0.44 | 0.05 | -0.84 | -0.73 | -0.27 |
| FCF Conversion (FCF/Net Income) | 0.38x | 1.30x | 1.05x | 0.69x | 0.67x | -0.34x | 0.69x | 0.76x | 0.44x |
| Interest Paid | 141K | 84K | 49K | 52K | 14K | 34K | 44K | 2.57M | 0 |
| Taxes Paid | 32K | 5K | 5K | 312K | 102K | 100K | 194K | 17K | 0 |
CDXS Key Ratios
Codexis, Inc. (CDXS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -40.77% | -105.38% | -26.91% | -14.75% | -17.42% | -12.72% | -21.73% | -65.89% | -85.03% | -74.88% |
| Return on Invested Capital (ROIC) | -4078.1% | - | -254.54% | -42.33% | -41.21% | -24.11% | -30.83% | -91.19% | -60.5% | -31.85% |
| Gross Margin | 80.03% | 71.36% | 79.17% | 77.17% | 80.1% | 78.8% | 72.56% | 81.74% | 72.55% | 79.49% |
| Net Margin | -17.52% | -45.97% | -17.95% | -17.43% | -34.77% | -20.31% | -24.24% | -108.69% | -109.99% | -62.47% |
| Debt / Equity | 0.02x | 0.01x | 0.00x | 0.25x | 0.15x | 0.29x | 0.30x | 0.19x | 0.89x | 1.45x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | -7.96x |
| FCF Conversion | 0.32x | 0.38x | 1.30x | 1.05x | 0.69x | 0.67x | -0.34x | 0.69x | 0.76x | 0.44x |
| Revenue Growth | 16.82% | 2.43% | 21.13% | 12.98% | 0.87% | 51.69% | 32.3% | -49.39% | -15.39% | 18.61% |
CDXS SEC Filings & Documents
Codexis, Inc. (CDXS) SEC filings — annual & quarterly reports (10-K, 10-Q)
CDXS Frequently Asked Questions
Codexis, Inc. (CDXS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Codexis, Inc. (CDXS) reported $70.4M in revenue for fiscal year 2025. This represents a 480% increase from $12.1M in 2006.
Codexis, Inc. (CDXS) grew revenue by 18.6% over the past year. This is strong growth.
Codexis, Inc. (CDXS) reported a net loss of $44.0M for fiscal year 2025.
Dividend & Returns
Codexis, Inc. (CDXS) has a return on equity (ROE) of -74.9%. Negative ROE indicates the company is unprofitable.
Codexis, Inc. (CDXS) had negative free cash flow of $23.8M in fiscal year 2025, likely due to heavy capital investments.
Explore More CDXS
Codexis, Inc. (CDXS) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates